Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype

SIMPLE SUMMARY: Trimodal therapy represents an accepted treatment option for non-metastatic muscle-invasive bladder cancer, which is an alternative to radical cystectomy. Evidence regarding trimodal therapy efficacy has predominantly, or even exclusively, been applied to urothelial carcinoma of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Barletta, Francesco, Tappero, Stefano, Panunzio, Andrea, Incesu, Reha-Baris, Cano Garcia, Cristina, Piccinelli, Mattia Luca, Tian, Zhe, Gandaglia, Giorgio, Moschini, Marco, Terrone, Carlo, Antonelli, Alessandro, Tilki, Derya, Chun, Felix K. H., de Cobelli, Ottavio, Saad, Fred, Shariat, Shahrokh F., Montorsi, Francesco, Briganti, Alberto, Karakiewicz, Pierre I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736026/
https://www.ncbi.nlm.nih.gov/pubmed/36497246
http://dx.doi.org/10.3390/cancers14235766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736026/
https://www.ncbi.nlm.nih.gov/pubmed/36497246
http://dx.doi.org/10.3390/cancers14235766

Ejemplares similares